Login / Signup

REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA -Related Dilated Cardiomyopathy.

Pablo García-PavíaJose Fernando Rodriguez PalomaresGianfranco SinagraRoberto Barriales VillaNeal K LakdawalaRobert L GottliebRandal I GoldbergPerry Mark ElliottPatrice LeeHuihua LiFranca S AngeliDaniel P JudgeCalum A MacRaenull null
Published in: Circulation. Heart failure (2024)
URL: https://classic.clinicaltrials.gov; Unique Identifiers: NCT03439514, NCT02057341, and NCT02351856.
Keyphrases
  • double blind
  • placebo controlled
  • open label
  • clinical trial
  • phase iii
  • study protocol
  • randomized controlled trial